Table 1 shows the number of patient samples with positive and negative immunostaining results for each marker and their distribution in the Combined Gleason Score. From all five makers, only cytoplasmic expression of SDC3 proved to be associated with an increased Gleason score and higher tumor stage (p = 0.0053). We also investigated the immunostaining patterns in the stromal components for SDCs and SDCBP, and besides some specificities, no prognostic value for these specificities was observed (Table S1 and Figure 4). This evidence concerns the gene SDCBP and neoplasm.